Below are the most recent publications written about "Skin Neoplasms" by people in Profiles.
-
Oka T, Smith SS, Oliver-Garcia VS, Lee T, Son HG, Mortaja M, Azin M, Garza-Mayers AC, Huang JT, Nazarian RM, Horn TD, Demehri S. Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer. Cell Rep. 2025 May 27; 44(5):115561.
-
Cabrera-Perez JS, Carey VJ, Odejide OO, Singh S, Kupper TS, Pillai SS, Weiss ST, Akenroye A. Integrative epidemiology and immunotranscriptomics uncover a risk and potential mechanism for cutaneous lymphoma unmasking or progression with dupilumab therapy. J Allergy Clin Immunol. 2025 May; 155(5):1584-1594.
-
Karpinski P, Mendez-Pena JE, Wu CL, Akalin A, Cornejo KM, Hung YP, Hoang MP. POU4F3 Is a Sensitive and Specific Marker of Merkel Cell Carcinoma. Mod Pathol. 2025 Jan; 38(1):100627.
-
Kumar EA, Morris LM, Michalski-McNeely BM. Tranexamic Acid in Mohs Micrographic Surgery: A Systematic Review. Dermatol Surg. 2025 01 01; 51(1):17-19.
-
Challapalli A, Stewart G, Shaw H, Davies PJ, Lopez-Baez JC, Ottley EC, Kelly S. Real-world evidence study on the early use of cemiplimab in the UK: REACT-CEMI (Real World evidence of advanced CSCC treatment with cemiplimab). Front Immunol. 2024; 15:1408667.
-
Kim DY, Behbahani S, Moncayo A, Trepanowski N, Hartman RI. Disparities in melanoma presentation and overall survival among disaggregated Hispanic nationalities: A retrospective analysis of 2,517 patients in the National Cancer Database. Arch Dermatol Res. 2024 Jun 08; 316(7):377.
-
Freeman T, Morris LM, Michalski BM. Legislative review and recommendations for improving sun protection in schools. Pediatr Dermatol. 2024 Jul-Aug; 41(4):654-659.
-
Curtis KL, Ho B, Jellinek NJ, Rubin AI, Tosti A, Lipner SR. Diagnosis and management of longitudinal erythronychia: A clinical review by an expert panel. J Am Acad Dermatol. 2024 Sep; 91(3):480-489.
-
Blashill AJ, Nogg K, Aguilar RAC, Roesch S, Brady J, Corliss HL, Pagoto S, Wells KJ. Skin cancer risk behaviors in sexual minority men: A mixed methods approach. Health Psychol. 2024 Jun; 43(6):462-475.
-
Laus AC, Gomes INF, da Silva ALV, da Silva LS, Milan MB, AparecidaTeixeira S, Martin ACBM, do Nascimento Braga Pereira L, de Carvalho CEB, Crovador CS, de Paula FE, Nascimento FC, de Freitas HT, de Lima Vazquez V, Reis RM, da Silva-Oliveira RJ. Establishment and molecular characterization of HCB-541, a novel and aggressive human cutaneous squamous cell carcinoma cell line. Hum Cell. 2024 Jul; 37(4):1170-1183.